Furthermore, alternative splicing events of SFT2D1 have been significantly associated with increased pancreatic cancer risk (Liu D. et al., 2023), suggesting a broader role in tumorigenesis. This evidence concerns the gene SFT2D1 and pancreatic neoplasm.